---
title: "INNOVITA establishes a new health technology company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249332014.md"
description: "According to the Qichacha APP, recently, Hangzhou INNOVITA Health Technology Co., Ltd. was established, with Zhang Le as the legal representative. The business scope includes: sales of Class I medical devices; sales of Class II medical devices; research and development of bio-based material technology, etc. Qichacha's equity penetration shows that the company is wholly owned by INNOVITA"
datetime: "2025-07-21T03:57:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249332014.md)
  - [en](https://longbridge.com/en/news/249332014.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249332014.md)
generator: "portal-rs"
---

# INNOVITA establishes a new health technology company

According to the Qichacha APP, recently, Hangzhou INNOVITA Health Technology Co., Ltd. was established, with Zhang Le as the legal representative. The business scope includes: sales of Class I medical devices; sales of Class II medical devices; research and development of bio-based material technology, etc. Qichacha's equity penetration shows that the company is wholly owned by INNOVITA

### Related Stocks

- [688253.CN](https://longbridge.com/en/quote/688253.CN.md)

## Related News & Research

- [REG - Michael Hennigan Checkit PLC - Form 8.3 - Checkit plc](https://longbridge.com/en/news/298625777.md)
- [Aignostics lance PathoSearch, un moteur de recherche visuel dédié aux cas pathologiques](https://longbridge.com/en/news/298827083.md)
- [ZAWYA: Emirates NBD tops UAE banking rankings as FAB makes strongest gains: YouGov](https://longbridge.com/en/news/298431388.md)
- [Definium Therapeutics to present Phase 3 Panorama topline data for DT120 in generalized anxiety disorder Sept. 14](https://longbridge.com/en/news/298839610.md)
- [US Cocoa Futures (COCOA-F) Is down 2.04% on Sep 10: Here Is Why](https://longbridge.com/en/news/298575877.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**